HOOKIPA Pharma Inc. (HOOK) News
Filter HOOK News Items
HOOK News Results
|Loading, please wait...|
Latest HOOK News From Around the Web
Below are the latest news stories about HOOKIPA PHARMA INC that investors may wish to consider to help them evaluate HOOK as an investment opportunity.
Hookipa stock surges 46% on license deal with Roche for immunotherapy
Roche (OTCQX:RHHBY) (OTCQX:RHHBF) signed a license agreement with Hookipa Pharma (NASDAQ:HOOK) to develop immunotherapy HB-700 for KRAS-mutated cancers and a second undisclosed novel arenaviral immunotherapy.
Under the agreement, Hookipa will receive $25M upfront. The Swiss pharma giant will have the option for an anothe...